69 Health Tech Startups in France to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Gene-editing platform. |
$30M · Series B | Khosla Ventures, Sanofi Ventures, Bpifrance | 11 to 50 | Health Tech, Biotech | Paris, France | •••••••••••@eligo.bio | ||
Immunotherapies developer for cancer patient. |
$4M · Seed | Fournier-Majoie, France 2030, Elaia | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@hephaistos-pharma.fr | ||
Mechatronic guidewires manufacturer. |
$6M · Series A | Forepont Capital Partners, NTI Corporation | 11 to 50 | Health Tech, Hardware | B2B | Paris, France | •••••••••••@basecampvascular.com | |
Biosensors developer to combat chronic kidney disease. |
$2M · Pre Seed | Bpifrance, Kima Ventures, Cenitz | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@metyos.com | ||
Robots for surgery. |
$55M · Series B | Sofinnova Partners, Cathay Innovation | 11 to 50 | Health Tech, Hardware, Deep Tech, Robotics, Manufacturing | B2B | Paris, France | •••••••••••@moonsurgical.com | |
AI software for radiologists. |
$29M · Series B | Bpifrance, Heal Capital, Elaia | 1 to 10 | Health Tech, AI | B2B | Paris, France | •••••••••••@gleamer.ai | |
Developer of digital health and wellness devices like fitness trackers and watches. |
$60M · Series B | 2050 | 101 to 250 | Health Tech, Hardware, Sportstech, Mobile, Manufacturing, Wearables | B2B | Paris, France | •••••••••••@withings.com | |
Biotechnology firm focused on life science advancements. |
$89M · Series A | Sofinnova Partners | 101 to 250 | Health Tech, Biotech | B2B | Paris, France | •••••••••••@mnemo-tx.com | |
Point-of-care diagnostic platform. |
$1M · Pre Seed | CentraleSupélec Venture | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@encarta.bio | ||
Biotechnology company focused on developing genomic medicines to treat blinding inherited retinal diseases. |
$52M · Series A | Ysios Capital | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | Paris, France | •••••••••••@sparingvision.com | |
AI-based platform for clinical trials. |
$2M · Seed | Bpifrance, Pfizer Healthcare Hub: London, Wilco | 1 to 10 | Health Tech, AI | B2B, SaaS | Paris, France | •••••••••••@klineo.fr | |
Platform enabling small and medium enterprises to effortlessly pay their employees. |
$79M · Series C | Accel, Eurazeo | 251 to 500 | Health Tech | B2B, SaaS | Paris, France | •••••••••••@payfit.com | |
Innovative heart pumps manufacturer. |
$28M · Series C | Bpifrance, Sofinnova Partners, Ysios Capital | 51 to 100 | Health Tech, Hardware | B2B | Paris, France | •••••••••••@corwave.com | |
AI-powered wound care monitoring platform. |
$3M · Seed | Bpifrance, Elaia, 50 Partners | 11 to 50 | Health Tech | B2B, SaaS | Paris, France | •••••••••••@pixacare.com | |
Digital health platform for women. |
$5M · Seed | Blisce, Vorwerk Ventures | 1 to 10 | Health Tech | B2C, SaaS | Paris, France | •••••••••••@sorella-care.com | |
Cybersecurity platform. |
$37M · Series A | Northcap | 101 to 250 | Health Tech, Hardware, Cybersecurity, Manufacturing | B2B, SaaS | Paris, France | •••••••••••@sekoia.io | |
Solution for protecting digestive anastomosis, designed to reduce complications. |
$47M | Sofinnova Partners | 1 to 10 | Health Tech, Hardware, Pharma, Manufacturing | B2B | Paris, France | •••••••••••@safeheal.com | |
Platform that develops bio factories to treat significant eye diseases sustainably. |
$30M · Series B | Karista, Pureos Bioventures | 11 to 50 | Health Tech, Hardware, Biotech, Manufacturing | B2B | Paris, France | •••••••••••@eyevensys.com | |
Medical devices for a transvascular treatment of pulmonary hypertension. |
$14M · Series A | Sofinnova Partners, Asabys Partners | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@gradientdenervation.com | ||
Network of independent health practices. |
$6M · Seed | 360 Capital | 11 to 50 | Health Tech | B2B, B2C | Paris, France | •••••••••••@centreviasana.com | |
Online platform providing residential assistance for seniors to help with daily activities at home. |
$31M · Series B | Future Positive Capital, XAnge | 51 to 100 | Health Tech | B2B, B2C, Marketplace | Paris, France | •••••••••••@ouihelp.fr | |
Biotechnology firm developing immunotherapies for cancer and autoimmune diseases. |
$46M | Bioqube Ventures | 11 to 50 | Health Tech, Biotech | B2B | Paris, France | •••••••••••@egle-tx.com | |
Remote monitoring system for ophthalmic conditions. |
$10M · Series A | Elaia, iBionext, Cap Horn | 11 to 50 | Health Tech | B2C | Paris, France | •••••••••••@tilakhealthcare.com | |
AI-powered precision immunology platform. |
$4M · Seed | CentraleSupélec Venture | 1 to 10 | Health Tech, AI | Paris, France | •••••••••••@scientalab.com | ||
Diagnostics technology for digital pathologies. |
$16M · Series B | Bpifrance, Starquest Capital | 11 to 50 | Health Tech, Enterprise Software | Paris, France | •••••••••••@tribvn-hc.com | ||
Platform for simple and secure exchange of medical letters. |
$22M · Series B | Daphni, Partech Ventures, Serena | 11 to 50 | Health Tech, Hardware | B2B, SaaS | Paris, France | •••••••••••@lifen.fr | |
Ulltrasound-based medical devices manufacturer to treat various brain disorders. |
$4M · Series B | Unorthodox Ventures, EIC Accelerator, Panakes Partners | 1 to 10 | Health Tech, Hardware | B2C | Paris, France | •••••••••••@carthera.eu | |
Digital care. Superpowered. Build engaging relationships with your patients through our machine learning-powered care platform. |
$20M | Firstminute Capital | 11 to 50 | Health Tech, AI, Mobile | B2C | Paris, France | •••••••••••@nabla.com | |
Exoskeleton enabling self-balanced walking for inpatient rehabilitation and daily outpatient use. |
$45M · Series C | XAnge | 51 to 100 | Health Tech, Hardware, Deep Tech, Robotics, Manufacturing | B2B | Paris, France | •••••••••••@wandercraft.eu | |
Digital mental health platform for employees. |
$10M · Series A | Bpifrance, Kima Ventures, Alter Equity 3P | 1 to 10 | Health Tech | B2B, SaaS | Paris, France | •••••••••••@teale.io | |
AI-powered prenatal screening solution. |
$14M · Series A | Bpifrance, Elaia, EIC Accelerator | 11 to 50 | Health Tech, Deep Tech | SaaS | Paris, France | •••••••••••@sonio.ai | |
Software that simplifies daily tasks for healthcare professionals, allowing them to focus on patient care. |
$25M · Series A | Revaia, Acton Capital | 51 to 100 | Health Tech | B2B, SaaS | Paris, France | •••••••••••@hublo.com | |
Diagnosis and prognosis tools for brain injured patients. |
$4M · Seed | Capital Grand Est | 1 to 10 | Health Tech | B2C | Paris, France | •••••••••••@braintale.fr | |
Biotechnology company based in Paris, focusing on innovative genetic analysis solutions. |
$12M | Eurazeo | 11 to 50 | Health Tech, Biotech, Genetics | B2B | Paris, France | •••••••••••@stillatechnologies.com | |
Solution for storing large amounts of computer data on long DNA strands at a low cost. |
$5M | Bpifrance | 1 to 10 | Health Tech, Biotech, Data and Analytics, Business Intelligence | Paris, France | •••••••••••@biomemory-labs.com | ||
High-resolution ultrasound imaging for stroke management. |
$2M · Seed | Bpifrance, Kima Ventures | 1 to 10 | Health Tech, Hardware | Paris, France | •••••••••••@resolvestroke.com | ||
PCOS infertility treatment developer. |
$10M · Series A | Bpifrance, Avestria Ventures, Trill Impact | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@mayhealth.com | ||
Platform that accelerates drug discovery using advanced computational techniques. |
$17M · Seed | Quantonation, XAnge | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Paris, France | •••••••••••@qubit-pharmaceuticals.com | |
Remote oncology patient monitoring platform. |
$5M · Seed | Red River West, Singular VC, Seaya Ventures | 101 to 250 | Health Tech | B2B, SaaS | Paris, France | •••••••••••@resilience.care | |
Platform connecting health care prescribers to ambulance companies. |
$6M · Series A | Kima Ventures, Partech Ventures | 1 to 10 | Health Tech, Mobility & Transportation | B2B, Marketplace | Paris, France | •••••••••••@ambler.fr | |
AI-based mental health monitoring platform. |
$2M · Seed | Bpifrance, 360 Capital | 1 to 10 | Health Tech, AI | B2C, SaaS | Paris, France | •••••••••••@callyope.com | |
Comms platform for phamarcists. |
$5M · Seed | Seedcamp, Connect Ventures, Cocoa | 1 to 10 | Health Tech | B2B, SaaS | Paris, France | •••••••••••@faks.co | |
Biotech solution providing NGS-based metagenomic tests to fully identify pathogens. |
$8M | Eurazeo, Norgine Ventures, Verve Ventures | 11 to 50 | Health Tech, Biotech | B2B | Paris, France | •••••••••••@pathoquest.com | |
Niodegradable sealants and adhesives for wound closure. |
$8M · Series A | Bpifrance, CM-CIC Capital Finance, Sofinnova Partners | 51 to 100 | Health Tech, Hardware, Biotech, Manufacturing | B2B | Paris, France | •••••••••••@tissium.com | |
Charles helps men regain control over their daily health concerns by starting with their personal health. |
$7M · Seed | Speedinvest | 1 to 10 | Health Tech, Ecommerce | B2C | Paris, France | •••••••••••@charles.co | |
Interceptive therapies for heart failure subpopulations. |
$12M · Seed | OrbiMed, Invivo Capital Partners, Omnes Capital | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@corteriapharma.com | ||
Developer of biotherapeutic products to treat cancer. |
$3M · Debt Financing | Bpifrance | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@everimmune.net | ||
Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases. |
$3M · Series F | The Leukemia & Lymphoma Society’s Therapy Acceleration Program, Omnes Capital, Nestlé Health Science | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Paris, France | •••••••••••@enterome.com | |
Biotech firm developing treatments for auto-immune diseases. |
$6M · Series A | Fountain Healthcare Partners | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Paris, France | •••••••••••@ermium.com | |
AI-driven digital twin heart image analysis solutions provider. |
$11M · Series A | Elaia, NACO, Vesalius Biocapital Partners | 11 to 50 | Health Tech, AI | B2B, SaaS | Bordeaux, France | •••••••••••@inheartmedical.com | |
App that helps you eat smarter and healthier by instantly analyzing the nutrients in your food. |
$4M | Demeter Partners | 1 to 10 | Health Tech, Foodtech, Fitness, Mobile, Consumer Social | B2C, Freemium | Paris, France | •••••••••••@foodvisor.io | |
Platform helping health professionals maintain and update their knowledge and skills throughout their careers. |
$3M · Seed | FJ Labs | 1 to 10 | Health Tech, Edtech, Media and Entertainement | B2B | Paris, France | •••••••••••@doctrio.com | |
Teledentistry company focused on France, Spain & Italy |
$2M · Seed | Newfund | 11 to 50 | Health Tech | B2C | Paris, France | •••••••••••@joovence.com | |
Bio-therapeutics company that develops and improves cell-based therapies in particular of cancer and other chronic diseases |
$2M · Pre Seed | Elaia | 1 to 10 | Health Tech, Biotech | B2B | Paris, France | •••••••••••@honing-biosciences.com | |
Data capture for clinical trials. |
$2M · Seed | Bpifrance | 11 to 50 | Health Tech, Pharma, Data and Analytics | B2B, SaaS | Paris, France | •••••••••••@kayentis.com | |
Experts in wellness through food |
$3M · Seed | DN Capital | 11 to 50 | Health Tech, Foodtech, Ecommerce | B2B, B2C, SaaS | Paris, France | •••••••••••@qilibri.fr | |
Platform to prevent cardiovascular risk and improve connected health. |
$4M | XAnge | 1 to 10 | Health Tech, Hardware, Manufacturing, Business Intelligence | B2B | Paris, France | •••••••••••@lifeaz.fr | |
Clinical support platform that helps healthcare professionals make better decisions throughout the patient journey. |
$2M · Seed | Cap Horn | 11 to 50 | Health Tech, AI, Machine Learning | B2B, SaaS | Paris, France | •••••••••••@posos.co | |
Subscription service delivering personalized food supplements to your doorstep. |
$2M | Kima Ventures, Newfund | 1 to 10 | Health Tech, Foodtech, Hardware, CPG & Consumer Goods, Mobile, Ecommerce | B2C, SaaS | Paris, France | •••••••••••@cuure.co | |
Platform for managing and directing money globally through a decentralized blockchain system. |
$2M · Series A | Truffle Capital | 1 to 10 | Health Tech, Fintech, Crypto & web3 | B2B, SaaS | Paris, France | •••••••••••@moneytrack.io | |
Platform for healthcare professionals offering universal remote cardiac monitoring and AI-powered FDA-cleared algorithms. |
$4M · Seed | Serena, XAnge, Karista | 51 to 100 | Health Tech, Hardware, AI, Business Intelligence | B2B, SaaS | Paris, France | •••••••••••@implicity.com | |
Platform for data collection and management to offer employers predictive analysis. |
$2M · Seed | Elaia | 11 to 50 | Health Tech, Service Industry | B2B, SaaS | Paris, France | •••••••••••@myc.doctor | |
Biotechnology platform developing advanced recombinant protein production technologies. |
$3M · Seed | Entrepreneur First, Thia Ventures, XAnge | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing | B2B | Paris, France | •••••••••••@corebiogenesis.com | |
Platform focused on making healthcare data easier to share and use. |
$4M · Series A | Newfund | 11 to 50 | Health Tech, Data and Analytics, Business Intelligence | B2B, SaaS | Paris, France | •••••••••••@arkhn.com | |
Corporate well-being platform. |
$1M · Seed | Finorpa | 1 to 10 | Health Tech | B2B, SaaS | Paris, France | •••••••••••@en.spart.life | |
Platform offering programs, activities, content, tools, and access to certified professionals for mental well-being. |
$2M · Seed | XAnge | 1 to 10 | Health Tech, Edtech, Mobile | B2B, SaaS | Paris, France | •••••••••••@mindday.com | |
Digital coaching platform for personalized development experiences. |
$2M · Seed | Kima Ventures, AXA Venture Partners, Educapital | 11 to 50 | Health Tech, Edtech, Fitness, Hiring and Recruitement | B2B, Marketplace | Paris, France | •••••••••••@simundia.com | |
Platform for healthcare professionals to exchange medical opinions. |
$3M · Seed | Newfund | 1 to 10 | Health Tech, Edtech | B2B, SaaS | Paris, France | •••••••••••@omnidoc.fr | |
Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1). |
$2M · Seed | Bpifrance, Idinvest Partners, AGORANOV | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Paris, France | •••••••••••@step-ph.com |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with.